What is CBD? Cannabidiol, CBDA and product terminology
What is CBD? CBD stands for cannabidiol, a compound in the plant-derived cannabinoid group. The name appears on oils and extracts and in scientific publications. However, CBD as an individual substance is not the same as a CBD-containing product. Distinguishing the key terms helps readers interpret descriptions more accurately and avoid misunderstandings.
Cannabidiol and THC: similar origins, different compounds
CBD and THC occur in the same plant-related chemical context but are not chemically or pharmacologically equivalent. Cannabidiol does not produce the characteristic THC ‘high’. ‘Non-intoxicating’, however, does not automatically mean free of adverse effects, suitable for everyone or without drug interactions. The PubChem substance database describes cannabidiol as a distinct chemical compound.
Another important point: although CBD itself is not THC, a CBD-containing extract may contain other substances. Statements about composition must therefore refer to the particular product, rather than merely to its best-known ingredient.
What is the difference between CBD and CBDA?
CBDA stands for cannabidiolic acid. During decarboxylation, a carboxyl group is removed, allowing CBDA to become CBD. Heat is one factor affecting this chemical process. An experimental study published in 2021 analysed the conversion of several cannabinoid acids under controlled extraction conditions. Read the original paper on thermal conversion.
Here, ‘acidic’ and ‘neutral’ forms describe a chemical distinction. They are not quality ratings. A study of CBDA is also not automatically evidence about CBD, or vice versa. This article provides no instructions for heating or processing products.
CBD oil and hemp seed oil are not the same
Hemp seed oil is a vegetable oil obtained from seeds. In common commercial terminology, CBD oil refers to an oil-based formulation with a stated CBD content. Depending on the formula, hemp seed oil or another oil may serve as the carrier. The ingredient list is decisive.
‘Hemp oil’ alone is therefore not a precise statement of CBD content. In an analytical investigation of commercial hemp seed oils, Citti and colleagues found differing cannabinoid profiles and developed a measurement method. Read the investigation of cannabinoids in hemp seed oil. A particular concentration cannot be inferred from the product name alone.
Isolate, full spectrum and broad spectrum explained
These commercial terms describe different compositions:
CBD isolate: CBD as a largely isolated single substance; its actual purity is established by the specification or analysis.
Full spectrum: usually describes an extract containing several components from the plant's chemical spectrum, potentially including THC.
Broad spectrum: usually describes a composition containing several components in which THC has been deliberately removed or reduced. The specific THC information must be checked separately.
These terms are not used with equal precision in every product description. Clear information about the individual formula and batch remains essential. None of these names alone establishes a scientifically validated ranking of medical efficacy.
What concentration and an analytical report tell us
A percentage initially describes a concentration. A valid comparison requires clarity about the substance, the reference quantity and the total amount contained in the product. A higher number does not automatically establish a better effect.
A batch-specific analytical report can help substantiate particular statements about ingredients. It should match the tested sample and identify the substances measured and their units. An analysis of cannabinoids, however, is neither evidence of treatment for a condition nor a test of every conceivable quality characteristic.
CBD as a pharmaceutical ingredient is a separate context
Cannabidiol is also the active ingredient in the prescription medicine Epidyolex. The European Medicines Agency describes its authorisation for certain rare epileptic conditions under specified circumstances. That assessment concerns the evaluated medicine, not every commercially available CBD oil.
For biological mechanisms and clinical studies, read the separate article How does CBD work?. It also explains why research findings cannot be turned into blanket product promises.
Conclusion: good CBD information starts with clear terminology
CBD, CBDA, hemp seed oil and a finished extract describe different things. Origin, concentration and composition help provide factual orientation; they do not replace evidence of efficacy. Find further background on our cannabidiol information page.
Please note: this article provides general information and does not replace medical advice. It contains no recommendations for ingestion or dosage and makes no health-efficacy claims for products in the Parmorcan® shop.
Sources and further evidence
The following sources are already linked in the text. The short English descriptions are provided for orientation; the original titles and bibliographic details are available in the linked publications.
Comments